Skip to main content
Intrasense logo

Intrasense — Investor Relations & Filings

Ticker · ALINS ISIN · FR0011179886 LEI · 969500VF6MOVQXWHAE33 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 313 across all filing types
Latest filing 2026-06-08 Regulatory Filings
Country FR France
Listing PA ALINS

About Intrasense

https://www.intrasense.fr/

Intrasense, a subsidiary of the Guerbet Group, is a medical technology company that develops and markets advanced software solutions for medical imaging. Its flagship product, the Myrian® platform, is a comprehensive visualization tool that assists healthcare professionals in reviewing and analyzing 2D and 3D medical images from modalities such as MRI and CT scanners. The company's solutions are characterized by the native integration of Artificial Intelligence (AI) algorithms to enhance diagnostic accuracy and workflow efficiency. Intrasense also offers specialized solutions, including Liflow® for oncology imaging and the DUOnco™ suite of AI tools for lesion detection. The technology aims to facilitate and secure clinical diagnosis, decision-making, and therapeutic monitoring for radiologists and other clinicians.

Recent filings

Filing Released Lang Actions
Intrasense et Guerbet annoncent la certification PMDA au Japon de DUOnco™ Pancreas, un logiciel d’IA conçu pour accompagner l’analyse des régions pancréatiques sur scanner injecté
Regulatory Filings Classification · 85% confidence The document is a press release announcing that DUOnco™ Pancreas received PMDA certification in Japan. It contains no financial statements, no earnings information, no management changes, nor investor presentation or meeting materials. It is effectively a regulatory/compliance announcement about device approval, which does not fit any of the specialized categories. Therefore, it should be classified as a general regulatory announcement (RNS).
2026-06-08 French
Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT
Regulatory Filings Classification · 85% confidence The document is a corporate press release announcing PMDA certification of a product (DUOnco™ Pancreas) in Japan. It does not contain financial statements, governance details, share transactions, call transcripts, or meeting materials. It’s not an earnings release, report publication announcement, or any formal regulatory form. As a miscellaneous corporate announcement that does not fit any of the other specific categories, it falls into the fallback category “Regulatory Filings (RNS).”
2026-06-08 English
Intrasense annonce les résultats de son Assemblée Générale Mixte des actionnaires du 2 juin 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a press release announcing the results of the Mixed Annual General Meeting (Assemblée Générale Mixte) of shareholders held on 2 June 2026, including quorum, votes cast, and adoption of resolutions. This is precisely a Declaration of Voting Results at a general meeting. It does not contain the full meeting materials or financial statements, but only the vote outcomes, fitting the DVA category.
2026-06-02 French
2025 Annual Results
Earnings Release Classification · 100% confidence The document is a press release titled '2025 Annual Results' issued by Intrasense. It provides a summary of financial performance, including revenue, operating income, and net income, along with management commentary on strategic developments and restructuring. While it contains financial data, it is a high-level summary announcement rather than a full 10-K or comprehensive annual report. According to the 'Menu vs Meal' rule, this is an Earnings Release (ER) as it serves as the initial announcement of periodic financial results. FY 2025
2026-03-11 English
Résultats annuels 2025
Earnings Release Classification · 95% confidence The document is a press release titled 'Résultats annuels 2025' (Annual Results 2025) issued by Intrasense. It provides a summary of financial highlights, including revenue growth, operational results, and management commentary on the company's strategic transformation. While it contains financial tables, it is clearly structured as a corporate press release (indicated by 'Communiqué de presse' at the bottom of pages) rather than a full statutory Annual Report (10-K). It serves as the initial announcement of the period's financial performance, fitting the definition of an Earnings Release. FY 2025
2026-03-11 French
Bilan semestriel du contrat de liquidité
Regulatory Filings Classification · 95% confidence The document is a 'Bilan semestriel du contrat de liquidité' (Half-year liquidity contract report) for Intrasense. This type of filing details the activity of a liquidity provider (TSAF) on behalf of the company, including the number of shares held and transactions conducted during the period. In the context of financial reporting, liquidity contract updates are considered regulatory disclosures regarding share capital and market activity, which fall under the 'Regulatory Filings' (RNS) category as they do not fit into specific categories like 'Transaction in Own Shares' (which usually refers to buybacks for cancellation or employee schemes) or 'Director's Dealing'.
2026-03-04 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.